Venture
Arbela Laboratories, Inc.
Latest Form D 2024-04-01- CIK 2013446
- State NJ
- Other
- 1 Form D offering since 2024-04-01
- Total sold
- $575K
- across its one offering
- Rounds
- 1
- Form D offerings since 2024-04-01
- Latest round
- $575K
- 2024-04-01 · 021-509259
- Investors
- 12
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-04-01 · $575K
- 2024-04-01$575K021-509259
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($575K)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-509259 | First filed2024-04-01 | Latest2024-04-01 | Sought$1.5M | Sold$575K | Investors12 | Exemptions504, 506(b), 4(a)(5) |
Who backs Arbela Laboratories, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-04-01
| Name | Relationship |
|---|---|
| Michael LoCascio | RelationshipExecutive Officer, Director, Promoter |
Facts
As its latest Form D states them
- Industry
- Other
- State
- New Jersey (NJ)
- Exemptions
- Rule 504(b)(1) (not (i), (ii) or (iii)); Rule 506(b); Securities Act Section 4(a)(5)
- First filed
- 2024-04-01
- Latest filing
- 2024-04-01
- Minimum investment
- $25K
Who backs Arbela Laboratories, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plans
External link: SEC Filings ↗